NCT04294576
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1
Drug Category: Immunotherapy, Therapeutic Antibody
Key Eligibility Criteria:
Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases:
Additional Notes: Breast cancer patients are only eligible for Phase 1a
Exclusions: Patients with uncontrolled CNS metastases
https://ClinicalTrials.gov/show/NCT04294576